Arizona Board of Pharmacy will be revising rules regarding office use and patient-specific compounding--office use only be permitted for resident pharmacies and at 5% cap

Ms. Sutcliffe stated that permits, fees, and statutes would be added for outsourcing facilities,
reverse distributors, and third party logistics providers.
Ms. Sutcliffe asked the Board Members what they would like to do concerning medications
compounded for office use.
Dr. Musil indicated that he feels that resident pharmacies should be able to compound
medications for doctor’s offices.
Dr. Musil stated that non-resident pharmacies should only be able to send patient-specific
medications into the state.
Ms. Sutcliffe asked what level of office use compounding would be appropriate. Dr. Musil
stated that he felt that 5% of total prescription sales would be appropriate.
Ms. Sutcliffe stated that she would revise the office use compounding section.

source